2025
GOVERNMENT TRANSITION
This site provides important information and updates from federal agencies that impact the Purdue University research enterprise.
Your resource for the latest information and updates
The site, developed and managed by the Executive Vice President for Research and Sponsored Program Services, includes timely information and guidance on what actions researchers should take during periods when the U.S. government administration or U.S. federal agency leadership are going through periods of transition.
PI Special Instructions
Special Notice – If you receive a questionnaire from any agency, please forward it to spsopers@groups.purdue.edu with a copy to avpsps@purdue.edu. SPS will coordinate a response with each principal investigator.
Forward agency communications, directives, questionnaires, certifications or requests for attestations on your current and pending awards to your Post Award administrator with a copy to spsopers@groups.purdue.edu. Before implementing new federal directives or policy changes, consult your assigned Post Award administrator to ensure compliance. As a reminder, contractual documents, certifications and other binding documents must be executed by Sponsored Program Services on behalf of the institution.
Updates from Federal Funding Agencies
This page catalogs executive orders, federal agency directives, litigation updates and other guidance and information pertaining to diversity, equity, inclusion and accessibility programs and policies.
This page catalogs executive orders, federal agency directives, litigation updates and other guidance and information affecting USAID and Department of State and programs funded through those organizations.
This page catalogs executive orders, federal agency directives, litigation updates and other guidance and information pertaining to the freeze of funds for research grants.
This page catalogs executive orders, federal agency directives, litigation updates and other guidance and information pertaining to the National Institutes of Health (NIH) indirect cost rate cap of 15%.